These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 36038916)
21. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression. Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228 [TBL] [Abstract][Full Text] [Related]
22. Pathological function of Ca2+-sensing receptor in pulmonary arterial hypertension. Yamamura A J Smooth Muscle Res; 2014; 50():8-17. PubMed ID: 24770445 [TBL] [Abstract][Full Text] [Related]
23. Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females. Dempsie Y; Nilsen M; White K; Mair KM; Loughlin L; Ambartsumian N; Rabinovitch M; Maclean MR Respir Res; 2011 Dec; 12(1):159. PubMed ID: 22185646 [TBL] [Abstract][Full Text] [Related]
24. Proteomic analysis of vascular smooth muscle cells in physiological condition and in pulmonary arterial hypertension: Toward contractile versus synthetic phenotypes. Régent A; Ly KH; Lofek S; Clary G; Tamby M; Tamas N; Federici C; Broussard C; Chafey P; Liaudet-Coopman E; Humbert M; Perros F; Mouthon L Proteomics; 2016 Oct; 16(20):2637-2649. PubMed ID: 27458111 [TBL] [Abstract][Full Text] [Related]
25. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice. Shimizu T; Fukumoto Y; Tanaka S; Satoh K; Ikeda S; Shimokawa H Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2780-91. PubMed ID: 24135024 [TBL] [Abstract][Full Text] [Related]
26. Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension. Xu D; Hu YH; Gou X; Li FY; Yang XY; Li YM; Chen F Molecules; 2022 Jun; 27(12):. PubMed ID: 35744848 [TBL] [Abstract][Full Text] [Related]
27. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension. Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428 [TBL] [Abstract][Full Text] [Related]
28. Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension. Li MX; Jiang DQ; Wang Y; Chen QZ; Ma YJ; Yu SS; Wang Y J Cardiovasc Pharmacol; 2016 Feb; 67(2):182-90. PubMed ID: 26448276 [TBL] [Abstract][Full Text] [Related]
29. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice. Huh JW; Kim SY; Lee JH; Lee YS Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment. Wołowiec Ł; Mędlewska M; Osiak J; Wołowiec A; Grześk E; Jaśniak A; Grześk G Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298685 [TBL] [Abstract][Full Text] [Related]
31. Cellular interplay in pulmonary arterial hypertension: implications for new therapies. Nogueira-Ferreira R; Ferreira R; Henriques-Coelho T Biochim Biophys Acta; 2014 May; 1843(5):885-93. PubMed ID: 24491811 [TBL] [Abstract][Full Text] [Related]
32. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension. Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577 [TBL] [Abstract][Full Text] [Related]
33. Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective. Wang RR; Yuan TY; Wang JM; Chen YC; Zhao JL; Li MT; Fang LH; Du GH Pharmacol Res; 2022 Jun; 180():106238. PubMed ID: 35504356 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension. Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128 [TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of pulmonary arterial remodeling. Crosswhite P; Sun Z Mol Med; 2014 Apr; 20(1):191-201. PubMed ID: 24676136 [TBL] [Abstract][Full Text] [Related]
36. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology. Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442 [TBL] [Abstract][Full Text] [Related]
37. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development. Dave J; Jagana V; Janostiak R; Bisserier M J Transl Med; 2023 Jul; 21(1):477. PubMed ID: 37461108 [TBL] [Abstract][Full Text] [Related]
38. Inflammation in Pulmonary Arterial Hypertension. Klouda T; Yuan K Adv Exp Med Biol; 2021; 1303():351-372. PubMed ID: 33788202 [TBL] [Abstract][Full Text] [Related]
39. Insights on the Gut-Mesentery-Lung Axis in Pulmonary Arterial Hypertension: A Poorly Investigated Crossroad. Oliveira SD Arterioscler Thromb Vasc Biol; 2022 May; 42(5):516-526. PubMed ID: 35296152 [TBL] [Abstract][Full Text] [Related]
40. TUG1 Regulates Pulmonary Arterial Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension. Wang S; Cao W; Gao S; Nie X; Zheng X; Xing Y; Chen Y; Bao H; Zhu D Can J Cardiol; 2019 Nov; 35(11):1534-1545. PubMed ID: 31679623 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]